Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Mariangela Manfredi and Arianna Damiani.
Connection Strength

1.118
  1. Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al. Ann Rheum Dis. 2020 Aug 04.
    View in: PubMed
    Score: 0.224
  2. Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD. Ann Rheum Dis. 2020 Jul 06.
    View in: PubMed
    Score: 0.223
  3. COVID-19 pneumonia treated with Sarilumab: A clinical series of eight patients. J Med Virol. 2020 11; 92(11):2368-2370.
    View in: PubMed
    Score: 0.222
  4. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives. Isr Med Assoc J. 2020 04; 22(4):203-210.
    View in: PubMed
    Score: 0.219
  5. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli et al. Ann Rheum Dis. 2021 10; 80(10):e166.
    View in: PubMed
    Score: 0.060
  6. Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab. Immunol Res. 2021 08; 69(4):309-311.
    View in: PubMed
    Score: 0.060
  7. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies. J Med Virol. 2021 03; 93(3):1436-1442.
    View in: PubMed
    Score: 0.056
  8. Old and new antirheumatic drugs for the treatment of COVID-19. Joint Bone Spine. 2020 05; 87(3):195-197.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.